|
 |
|
ชื่อ-สกุล: |
ศาสตราจารย์ ดร.มัลลิกา อิ่มวงศ์ |
Name: |
Professor Mallika Imwong |
ตำแหน่ง: |
หัวหน้าภาควิชา |
Position: |
Head |
สังกัด : |
ภาควิชาชีวโมเลกุลและพันธุศาสตร์โรคเขตร้อน |
Department: |
Molecular Tropical Medicine and Genetics |
Tel: |
02 306 9100 ต่อ 3078, 1440-1443 |
E-mail: |
mallika.imw@mahidol.ac.th |
|
|
|
|
|
Field of Expertise |
|
Molecular Characterisation of Drug Resistance in the Human Malarias |
|
Genotyping of Plasmodium vivax |
|
Pharmacogenetic basis of Oseltamivir |
|
G6PD genotyping |
|
|
Professional Achievements
|
|
Member of scientific committee for ‘Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations’ sponsored by Medicines for Malaria Venture and cosponsored by World Health. |
|
Head of Molecular Regional Reference Laboratory for Asia, organized and supported by WorldWide Antimalarial Resistance Network (WWARN)’ since 2008. |
|
Invited reviewer of manuscripts for international journals including Trends in Parasitology, The Journal of Infectious Diseases, and Malaria Journal. |
|
|
Research grant received |
|
Principle investigator: Wellcome Trust Career Development Research Fellowship in Public Health and Tropical Medicine, Wellcome Trust of Great Britain Title: ‘Molecular Characterisation of Drug Resistance in the Human Malarias’ during |
|
Principle investigator: National Science and Technology Development Agency, Bangkok, Thailand, Title: VNTR typing of Plasmodium falciparum and Plasmodium vivax. |
|
Principle investigator: The Thailand Research Fund, Bangkok, Thailand, Title: Development of molecular techniques for evaluation of mefloquine resistance in P. falciparum in Asia. |
|
Principle investigator: Wellcome Trust Training Fellow for Research into Infectious Diseases, Wellcome Trust of Great Britain Title: Genotyping of Plasmodium vivax; development of field methods and investigation of the molecular basis of sulfonamide resistance. |
|
Co-investigator: Wellcome Trust of Great Britain, Title: Population biology and epidemiology of two newly recognized human malaria parasite species |
|
Co-investigator: United States Agency for International Development (USAID), Title:Molecular Surveillance of Drug Resistant Malaria in the Greater Mekong Subregion. |
|
Co-investigator: NIH, Title: Characterisation of the Human Carboxylesterase 1 (CES1) mutation(s) which may be responsible for markedly reduced conversion of oseltamivir phosphate to oseltamivir carboxylate |
|
Co-investigator: The Thailand Research Fund, Bangkok, Thailand, Title: Studies on virulent and drug resistant genes of malarial parasites from infected patients for development of molecular test kits |
|
|
|
Last updated: May 21, 2019 |
|